SUBSCRIBE
SUBSCRIBE
Gail Dutton

Gail Dutton

Freelance writer

Gail Dutton is a veteran biopharmaceutical reporter, covering the industry from Washington state. You can contact her at gaildutton@gmail.com and see more of her work on Muckrack.

Draper’s Tumor-on-a-Chip Parallels In Vivo Findings of Checkpoint Inhibitor Efficacy in Mice
Draper, in one of the latest lab-on-a-chip advances, has shown that its dynamic, in vitro tumor microenvironment can be used to distinguish tumor responses against two different checkpoint inhibitors in three mouse lines.
September 29, 2020
 · 
4 min read
 · 
Gail Dutton
Courtesy Shutterstock
Business
A Fireside Chat with J.P. Morgan’s Michael Gaito, Head of Healthcare Investment Banking
At a recent Demy-Colton Virtual Salon, Michael Gaito, head of healthcare investment banking at J.P. Morgan, discussed the strength of capital raises despite COVID-19 and the resilient state of the biotech sector in the run-up to the Presidential election in November and the virtual J.P. Morgan Healthcare Conference (and the virtual Biotech Showcase) in January, with Dennis Purcell, founder of Aisling Capital LLC.
September 29, 2020
 · 
5 min read
 · 
Gail Dutton
Job Trends
Sanofi’s Toujeo Improves Diabetes Control, Giving Patients More Time in Range
For diabetic patients, achieving a certain “time in range” is a more realistic glucose control strategy than striving for a particular daily target, according to researchers working with Sanofi who spoke during the 56th Annual Meeting of the European Association for the Study of Diabetes.
September 24, 2020
 · 
5 min read
 · 
Gail Dutton
Drug Development
What Next-Generation COVID-19 Antibody Therapeutics Need to Succeed
First-generation therapeutics have been largely ineffective against the SARS-CoV-2 virus, resulting in significant challenges and opportunities for the second-generation therapeutics that are being designed now.
September 24, 2020
 · 
4 min read
 · 
Gail Dutton
Biotech Beach
Locanabio’s RNA-Targeting Gene Therapy May Offer Durable Response for DM1 Patients
RNA-binding proteins are emerging as the next generation of molecular medicine.
September 23, 2020
 · 
3 min read
 · 
Gail Dutton
Business
Temperature-Controlled Packaging Demand Reveals Need for Proactive COVID-19 Trial Planning
Competition for resources is growing, and the usual supply chain partners may not have available capacity in the preferred timeframe.
September 21, 2020
 · 
5 min read
 · 
Gail Dutton
Progentec’s Novel Blood Test Predicts Lupus Flares Up to 12 Weeks Before They Occur
Progentec Diagnostics, Inc. just launched a novel blood test to determine the likelihood that a patient with systemic lupus erythematosus (commonly known as both SLE and lupus) will experience an immunologic disease flare during the coming 12 weeks.
September 20, 2020
 · 
4 min read
 · 
Gail Dutton
BDO to Biotech Companies: Realign Pipelines for Survival Today and Growth Tomorrow
Biotech needs to get tougher on pipeline decisions, according to BDO’s recently released annual Biotech Briefing.
September 18, 2020
 · 
5 min read
 · 
Gail Dutton
Policy
Prepping for COVID-19’s Next Wave: Is the Glass Half Full or Half Empty?
With both autumn and flu season fast approaching, nearly everyone is wondering whether we will endure another round of illnesses that will rival that of last spring.
September 16, 2020
 · 
4 min read
 · 
Gail Dutton
Pharm Country
iBio’s FastPharming® Platform Produces Decoy Therapeutic to Bind to SARS-CoV-2
Recently licensed from Planet Biotechnology, the candidate is a recombinant protein made from human angiotensin converting enzyme 2 (ACE2) fused to a human immunoglobulin G Fc fragment.
September 15, 2020
 · 
4 min read
 · 
Gail Dutton
Business
Strand Therapeutics’ mRNA Logic Circuits Enhance Gene Therapy’s Safety, Ease and Controllability
The company is genetically programming RNA not just to deliver a gene of interest, but to control the location, timing and intensity of therapeutic protein expression using mRNA-encoded logic circuits.
September 14, 2020
 · 
4 min read
 · 
Gail Dutton
Pictured: Chinese flags in a row/iStock
With U.S.-China Relations Tremulous, Is China Still a Good Place to Do Business?
When biotech companies consider conducting business in China, their concerns are radically different than they were even four years ago.
September 14, 2020
 · 
4 min read
 · 
Gail Dutton
Use of AI in medical field.
Drug Development
AI in Medical Field for Clinical Trials Increase, Refining Endpoints, Quantifying Pain, & More
Ai in medical field is helping the researchers at clinical stage research by increasing the efficiency, refining endpoints and quantifying pain, and much more.
September 4, 2020
 · 
4 min read
 · 
Gail Dutton
Pharm Country
Lessons From Bergamo: Halting the Complement Cascade May Stop COVID-19 in Its Tracks
Treatments for COVID-19 may be focusing on at the wrong elements of the disease, according to physicians analyzing results from Bergamo, Italy, the epicenter of the pandemic in Europe.
September 3, 2020
 · 
4 min read
 · 
Gail Dutton
Genetown
PEGS Boston: Accelerating Antibody Engineering with Structured Data and Automation
The use of structured data and automation can accelerate antibody engineering as much as 50%, Prem Mohanty, product marketing manager and life sciences product specialist for Benchling, told BioSpace.
September 3, 2020
 · 
4 min read
 · 
Gail Dutton
Load More